Results
8541
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,541 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GAU | CA$1.95 | -2.5% | 116.7% | CA$501.0m | CA$3.30 | PE38.1x | E31.2% | n/a | Materials | ||
AXSM | US$95.84 | 3.7% | 35.5% | US$4.6b | US$125.24 | PS15.8x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$22.66 | 6.0% | -4.6% | US$2.5b | US$26.00 | PE17x | E42.1% | 4.1% | Energy | ||
SRPT | US$127.21 | 2.3% | 10.9% | US$12.1b | US$194.36 | PE256.5x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$29.18 | 5.1% | 96.1% | US$4.8b | US$35.33 | PS22.3x | E95.0% | n/a | Semiconductors | ||
ZVRA | US$8.06 | 3.6% | 68.3% | US$424.1m | US$18.00 | PS17.9x | E69.5% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$116.00 | -0.7% | 174.7% | US$2.8t | US$148.83 | PE53.7x | E22.3% | 0.03% | Semiconductors | ||
ARES | US$156.66 | 4.9% | 48.2% | US$49.0b | US$150.23 | PE82.7x | E32.9% | 2.4% | Diversified Financials | ||
AOT | CA$0.16 | -8.6% | -61.0% | CA$113.0m | n/a | PS46.7x | E46.9% | n/a | Materials | ||
EH | US$11.91 | 0.3% | -29.4% | US$753.7m | US$24.76 | PS21.3x | E81.5% | n/a | Capital Goods | ||
TVTX | US$15.21 | 6.6% | 88.9% | US$1.2b | US$17.60 | PS6.5x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$24.65 | -1.0% | 174.5% | US$3.5b | US$33.75 | PE37x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
4480 | JP¥3,445.00 | 8.2% | -30.0% | JP¥111.9b | JP¥5,400.00 | PE41.6x | E30.4% | n/a | Healthcare | ||
5038 | JP¥1,809.00 | -0.3% | -2.3% | JP¥27.1b | n/a | PE39.4x | E27.5% | 0.6% | Healthcare | ||
7373 | JP¥1,535.00 | 3.9% | -29.3% | JP¥23.4b | JP¥4,600.00 | PE23.2x | E32.7% | 2.0% | Commercial Services | ||
7096 | JP¥1,655.00 | 1.3% | -36.3% | JP¥17.0b | n/a | PE41.1x | E38.4% | n/a | Healthcare | ||
LAVV3 | R$8.29 | -5.3% | 9.9% | R$1.6b | R$12.98 | PE5.9x | E21.1% | 3.4% | Real Estate Management and Development | ||
MVW | NOK 10.20 | -10.5% | 25.0% | NOK 333.7m | NOK 12.20 | PS19.4x | E70.8% | n/a | Materials | ||
CADLR | NOK 70.70 | 1.7% | 91.9% | NOK 24.8b | NOK 81.94 | PS17.2x | E67.8% | n/a | Capital Goods | ||
AFISH | NOK 45.00 | -3.4% | -50.0% | NOK 1.4b | NOK 81.00 | PS1.5x | E98.9% | n/a | Food, Beverage & Tobacco | ||
FWRY | ج.م8.34 | 8.3% | 55.6% | ج.م28.4b | ج.م11.44 | PE29.5x | E29.4% | n/a | Diversified Financials | ||
RMDA | ج.م2.89 | 12.0% | 101.1% | ج.م4.3b | ج.م4.11 | PE19.2x | E30.2% | 2.3% | Pharmaceuticals & Biotech | ||
9992 | HK$48.70 | -0.9% | 107.2% | HK$64.5b | HK$53.85 | PE38.3x | E29.3% | 0.6% | Retail | ||
NEWBRY | SEK 3.02 | -5.0% | -21.8% | SEK 73.3m | SEK 8.00 | PS4x | E116.2% | n/a | Pharmaceuticals & Biotech |